CD163 and non-small cell lung carcinoma: MDSCs were positively correlated with CD68+CD163+M2-like macrophages in NSCLC patients during radiotherapy, indicating that upregulating them could provide auxiliary and sensitive biomarkers for NSCLC diagnosis and predict a better therapeutic response of NSCLC patients in radiotherapy.